In conversation with...

Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas

June 14, 2022 The Lancet Gastroenterology & Hepatology
In conversation with...
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
Show Notes

Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.

Read the full article:
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II)